<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table4" position="float"><object-id pub-id-type="doi">10.7554/eLife.31549.019</object-id><label>Table 4.</label><caption><title>Laboratory abnormalities per study arm.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top"/><th colspan="3" valign="top"><bold>LD-SP/SP</bold></th><th colspan="3" valign="top"><bold>LD-SP/PIP</bold></th><th colspan="3" valign="top"><bold>LD-PIP/PIP</bold></th><th colspan="3" valign="top"><bold>LD-PIP/SP</bold></th></tr><tr><th valign="top"/><th valign="top">N (% of total) of grade 1</th><th valign="top">N (% of total) of grade 2</th><th valign="top">N (% of total) of grade 3</th><th valign="top">N (% of total) of grade 1</th><th valign="top">N (% of total) of grade 2</th><th valign="top">N (% of total) of grade 3</th><th valign="top">N (% of total) of grade 1</th><th valign="top">N (% of total) of grade 2</th><th valign="top">N (% of total) of grade 3</th><th valign="top">N (% of total) of grade 1</th><th valign="top">N (% of total) of grade 2</th><th valign="top">N (% of total) of grade 3</th></tr></thead><tbody><tr><td valign="top">Any lab. abnormality</td><td valign="top">15 (14)</td><td valign="top">7 (7)</td><td valign="top">2 (2)</td><td valign="top">13 (12)</td><td valign="top">10 (9</td><td valign="top">3 (3)</td><td valign="top">16 (15)</td><td valign="top">9 (8)</td><td valign="top">2 (2)</td><td valign="top">13 (12)</td><td valign="top">8 (8)</td><td valign="top">8 (8)</td></tr><tr><td valign="top">Decreased hemoglobin</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">1 (14)</td><td valign="top">2 (29)</td><td valign="top">0</td><td valign="top">1 (14)</td><td valign="top">1 (14)</td><td valign="top">0</td><td valign="top">1 (14)</td><td valign="top">1 (14)</td><td valign="top">0</td></tr><tr><td valign="top">Decreased WBC</td><td valign="top">1 (8)</td><td valign="top">3 (23)</td><td valign="top">0</td><td valign="top">1 (8)</td><td valign="top">2 (15)</td><td valign="top">0</td><td valign="top">1 (8)</td><td valign="top">2 (15)</td><td valign="top">0</td><td valign="top">1 (8)</td><td valign="top">2 (15)</td><td valign="top">0</td></tr><tr><td valign="top">Decreased neutrophils</td><td valign="top">3 (23)</td><td valign="top">1 (8)</td><td valign="top">0</td><td valign="top">2 (15)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">3 (23)</td><td valign="top">1 (8)</td><td valign="top">0</td><td valign="top">3 (23)</td><td valign="top">0</td><td valign="top">0</td></tr><tr><td valign="top">Decreased lymphocytes</td><td valign="top">3 (20)</td><td valign="top">1 (7)</td><td valign="top">0</td><td valign="top">1 (7)</td><td valign="top">3 (20)</td><td valign="top">0</td><td valign="top">3 (20)</td><td valign="top">1 (7)</td><td valign="top">0</td><td valign="top">1 (7)</td><td valign="top">2 (13)</td><td valign="top">0</td></tr><tr><td valign="top">Decreased platelets</td><td valign="top">3 (25)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">2 (17)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">4 (33)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">1 (8)</td><td valign="top">2 (17)</td><td valign="top">0</td></tr><tr><td valign="top">Elevated ALT</td><td valign="top">2 (13)</td><td valign="top">1 (6)</td><td valign="top">1 (6)</td><td valign="top">2 (13)</td><td valign="top">0</td><td valign="top">2 (13)</td><td valign="top">1 (6)</td><td valign="top">2 (13)</td><td valign="top">1 (6)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">4 (25)</td></tr><tr><td valign="top">Elevated AST</td><td valign="top">1 (7)</td><td valign="top">1 (7)</td><td valign="top">1 (7)</td><td valign="top">2 (13)</td><td valign="top">1 (7)</td><td valign="top">1 (7)</td><td valign="top">1 (7)</td><td valign="top">2 (13)</td><td valign="top">1 (7)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">4 (27)</td></tr><tr><td valign="top">Elevated yGT</td><td valign="top">1 (11)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">1 (11)</td><td valign="top">1 (11)</td><td valign="top">0</td><td valign="top">2 (22)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">3 (33)</td><td valign="top">1 (11)</td><td valign="top">0</td></tr><tr><td valign="top">Elevated ALP</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">1 (33)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">2 (67)</td><td valign="top">0</td><td valign="top">0</td></tr><tr><td valign="top">Elevated total bilirubin</td><td valign="top">1 (50)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">1*(50)</td><td valign="top">0</td><td valign="top">0</td></tr><tr><td valign="top">Elevated creatinine</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">1 (100)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td></tr><tr><td valign="top">Elevated BUN</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td><td valign="top">0</td></tr></tbody></table><table-wrap-foot><fn><p>Number of subjects with the highest grade reported for a laboratory abnormality. Grading based on WHO toxicity grading scale. No grade four abnormalities were reported. Lymphocytes (10<sup>9</sup>/l) were graded based on grade 1: 0.9&#8211;0.6; grade 2: 0.3&#8211;0.5; grade 3:&lt;0.3.</p><p>Liver function tests were graded based on grade 1: 1.1.&#8211;2.5X ULN, grade 2: 2.6&#8211;5.0x ULN, grade 3:&gt;5.0X ULN. WBC, white blood count; ALT, alanine aminotransferase; AST, aspartate aminotransferase; yGT, glutamyl transpeptidase; ALP, alkaline phosphatase;</p></fn><fn><p>See <xref ref-type="fig" rid="fig6s1">Figure 6&#8212;figure supplement 1</xref> for a detailed overview of liver function test abnormalities.</p><p>BUN, blood urea nitrogen. T1, treatment 1; T2, treatment 2.*Subject showed elevated total bilirubin at baseline.</p></fn></table-wrap-foot></table-wrap>